World's Best Scientists 2026 revealed!
Ken Shirabe

Ken Shirabe

D-Index & Metrics

Medicine

D-Index
88
Citations
39008
World Ranking
12954
National Ranking
380

Overview

Ken Shirabe is affiliated with Gunma University in Japan and has an extensive body of research mainly focused on medicine, with particular contributions in surgery, oncology, pulmonary and respiratory medicine, molecular biology, and hepatology. Their publication record reflects a strong engagement in clinical and experimental cancer research.

The scientist's recent publications cover several aspects of cancer biology and treatment. Notable papers include:

  • High L-Type Amino Acid Transporter 1 Levels Are Associated with Chemotherapeutic Resistance in Gastric Cancer Patients (2021, Oncology)
  • Nintedanib inhibits intrahepatic cholangiocarcinoma aggressiveness via suppression of cytokines extracted from activated cancer-associated fibroblasts (2020, British Journal of Cancer)
  • Diagnostic value of 18F-FDG-PET to predict the tumour immune status defined by tumoural PD-L1 and CD8+tumour-infiltrating lymphocytes in oral squamous cell carcinoma (2020, British Journal of Cancer)
  • Implications of Low Serum Albumin as a Prognostic Factor of Long-term Outcomes in Patients With Breast Cancer (2020, In Vivo)
  • Targetable ERBB2 mutation status is an independent marker of adverse prognosis in estrogen receptor positive, ERBB2 non-amplified primary lobular breast carcinoma: a retrospective in silico analysis of public datasets (2020, Breast Cancer Research)

Ken Shirabe frequently collaborates with several coauthors, indicating a broad collaborative network in their research endeavors. The top collaborators include:

  • Makoto Sohda (115 joint publications)
  • Takehiko Yokobori (99 joint publications)
  • Akihiko Sano (93 joint publications)
  • Hiroomi Ogawa (88 joint publications)
  • Makoto Sakai (87 joint publications)

The scientist's works have been published in a variety of academic journals, with repeated contributions to the following publication venues:

  • Anticancer Research (28 publications)
  • Surgical Case Reports (27 publications)
  • Annals of Surgical Oncology (22 publications)
  • Surgery Today (18 publications)
  • Annals of Gastroenterological Surgery (17 publications)

Ken Shirabe's research spans several main fields and related subfields, highlighting a focus on surgical and oncological areas particularly relevant to cancer management:

  • Main field: Medicine (868 publications)
  • Subfields: Surgery (210), Oncology (200), Pulmonary and Respiratory Medicine (172), Molecular Biology (59), Hepatology (53)

The primary research topics explored by Ken Shirabe include key domains of cancer and related conditions, reflecting a multidisciplinary approach to disease management and prognosis:

  • Gastric Cancer Management and Outcomes (92 publications)
  • Pancreatic and Hepatic Oncology Research (84 publications)
  • Esophageal Cancer Research and Treatment (74 publications)
  • Cancer Immunotherapy and Biomarkers (70 publications)
  • Hepatocellular Carcinoma Treatment and Prognosis (64 publications)
  • Esophageal and GI Pathology (58 publications)
  • Nutrition and Health in Aging (50 publications)

Best Publications

  • Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Daniel J. Klionsky;Kotb Abdelmohsen;Akihisa Abe;Joynal Abedin

  • Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Daniel J. Klionsky;Kotb Abdelmohsen;Akihisa Abe;Joynal Abedin

  • Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume

    Ken Shirabe;Mitsuo Shimada;Tomonobu Gion;Hirofumi Hasegawa

  • Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma

    N. Harimoto;K. Shirabe;Y. I. Yamashita;Toru Ikegami

  • Neutrophil–lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment

    Takashi Motomura;Ken Shirabe;Yohei Mano;Jun Muto

  • Bile Leakage After Hepatic Resection

    Yo Ichi Yamashita;Takayuki Hamatsu;Tatsuya Rikimaru;Shinji Tanaka

  • Factors linked to early recurrence of small hepatocellular carcinoma after hepatectomy: Univariate and multivariate analyses

    Ken Shirabe;Takashi Kanematsu;Takashi Matsumata;Eisuke Adachi

  • Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival after hepatectomy for hepatocellular carcinoma: a retrospective analysis.

    Yohei Mano;Ken Shirabe;Yo Ichi Yamashita;Norifumi Harimoto

  • Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma.

    Eisuke Adachi;Takashi Maeda;Takashi Matsumata;Ken Shirabe

  • Sarcopenia is a prognostic factor in living donor liver transplantation

    Toshiro Masuda;Ken Shirabe;Toru Ikegami;Norifumi Harimoto

  • Identification of a bona fide microRNA biomarker in serum exosomes that predicts hepatocellular carcinoma recurrence after liver transplantation

    K Sugimachi;T Matsumura;H Hirata;R Uchi

  • Genome-wide association study identifies TNFSF15 and POU2AF1 as susceptibility loci for primary biliary cirrhosis in the Japanese population.

    Minoru Nakamura;Nao Nishida;Minae Kawashima;Yoshihiro Aiba

  • Results of 280 Liver Resections for Hepatocellular Carcinoma

    Kenji Takenaka;Naoyuki Kawahara;Kazuharu Yamamoto;Kiyoshi Kajiyama

  • Prognosis of Recurrent Hepatocellular Carcinoma: A 10-Year Surgical Experience in Japan

    Mitsuo Shimada;Kenji Takenaka;Tomonobu Gion;Yuh Fujiwara

  • Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Daniel J. Klionsky;Kotb Abdelmohsen;Akihisa Abe;Joynal Abedin

  • Variants in IL28B in liver recipients and donors correlate with response to peg-interferon and ribavirin therapy for recurrent hepatitis C.

    Takasuke Fukuhara;Akinobu Taketomi;Takashi Motomura;Shinji Okano

  • The predictors of microvascular invasion in candidates for liver transplantation with hepatocellular carcinoma-with special reference to the serum levels of des-gamma-carboxy prothrombin.

    Ken Shirabe;shinji itoh;Tomoharu Yoshizumi;Yuji Soejima

  • Trends in morbidity and mortality after hepatic resection for hepatocellular carcinoma: an institute's experience with 625 patients.

    Akinobu Taketomi;Dai Kitagawa;Shinji Itoh;Norifumi Harimoto

  • Electroporation-mediated Interleukin-12 Gene Therapy for Hepatocellular Carcinoma in the Mice Model

    Yo-ichi Yamashita;Mitsuo Shimada;Hirofumi Hasegawa;Ryosuke Minagawa

  • Value of lymph node dissection during resection of intrahepatic cholangiocarcinoma

    M Shimada;Y Yamashita;S Aishima;K Shirabe

Frequent Co-Authors

Yoshihiko Maehara
Yoshihiko Maehara Kyushu University
Akinobu Taketomi
Akinobu Taketomi Hokkaido University
Mitsuo Shimada
Mitsuo Shimada University of Tokushima
Hiroyuki Kuwano
Hiroyuki Kuwano Gunma University
Keizo Sugimachi
Keizo Sugimachi Kyushu University
Yoshinao Oda
Yoshinao Oda Kyushu University
Hiroshi Honda
Hiroshi Honda Kyushu University
Hideo Baba
Hideo Baba Kumamoto University
Shinji Shimoda
Shinji Shimoda Kyushu University
Koshi Mimori
Koshi Mimori Kyushu University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative pathways in healthcare can diversify your career after studying Medicine in the USA. Many professionals consider advanced online degrees for flexibility and accessibility, especially if balancing work or personal commitments.

For those interested in hospital administration or leadership, earning an MHA online is a popular option. You can review a cahme accredited online mha programs list to ensure your program is recognized and meets high standards for healthcare management education.

Registered nurses seeking to advance their qualifications may benefit from bridge programs, such as rn to bsn no clinical hours options. These pathways allow working professionals to complete their bachelor’s without onsite clinical requirements.

Nurses aiming for the highest clinical roles should consider doctoral programs. Look into accelerated msn to dnp programs for an efficient transition, or find a cheapest dnp program to minimize expenses while maximizing clinical impact. These options streamline your journey toward advanced nursing practice and leadership.

Best Scientists Citing Ken Shirabe

Trending Scientists

Recently Published Articles